Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 4 studies | 20% ± 4% | |
epithelial cell | 4 studies | 33% ± 11% | |
glutamatergic neuron | 4 studies | 23% ± 7% | |
natural killer cell | 4 studies | 23% ± 8% | |
hematopoietic precursor cell | 3 studies | 25% ± 4% | |
ciliated cell | 3 studies | 31% ± 4% | |
erythroblast | 3 studies | 31% ± 20% | |
GABAergic neuron | 3 studies | 20% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 16% ± 2% | |
dendritic cell | 3 studies | 21% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 20% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 519.90 | 1445 / 1445 | 100% | 42.30 | 183 / 183 |
ovary | 100% | 541.29 | 180 / 180 | 100% | 52.86 | 430 / 430 |
stomach | 100% | 493.83 | 359 / 359 | 99% | 41.02 | 284 / 286 |
breast | 100% | 656.77 | 459 / 459 | 99% | 44.94 | 1110 / 1118 |
intestine | 100% | 549.82 | 966 / 966 | 99% | 43.92 | 523 / 527 |
brain | 99% | 542.17 | 2620 / 2642 | 100% | 44.18 | 705 / 705 |
lung | 99% | 462.30 | 574 / 578 | 100% | 41.72 | 1153 / 1155 |
uterus | 100% | 525.31 | 170 / 170 | 99% | 43.37 | 454 / 459 |
thymus | 100% | 564.98 | 653 / 653 | 99% | 30.09 | 597 / 605 |
bladder | 100% | 463.71 | 21 / 21 | 99% | 50.85 | 497 / 504 |
prostate | 100% | 507.51 | 245 / 245 | 98% | 33.66 | 494 / 502 |
pancreas | 99% | 607.69 | 326 / 328 | 98% | 24.81 | 175 / 178 |
adrenal gland | 100% | 720.97 | 258 / 258 | 96% | 26.35 | 221 / 230 |
kidney | 100% | 495.07 | 89 / 89 | 93% | 19.40 | 835 / 901 |
liver | 98% | 274.42 | 222 / 226 | 91% | 17.34 | 370 / 406 |
skin | 100% | 594.98 | 1805 / 1809 | 89% | 30.10 | 421 / 472 |
adipose | 100% | 528.38 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 549.85 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.73 | 29 / 29 |
spleen | 100% | 563.16 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.09 | 1 / 1 |
muscle | 100% | 445.68 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 372.84 | 812 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 571.35 | 660 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 12.81 | 50 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000278 | Biological process | mitotic cell cycle |
GO_2000779 | Biological process | regulation of double-strand break repair |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0007010 | Biological process | cytoskeleton organization |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0000786 | Cellular component | nucleosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0035267 | Cellular component | NuA4 histone acetyltransferase complex |
GO_0016363 | Cellular component | nuclear matrix |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042393 | Molecular function | histone binding |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0140030 | Molecular function | modification-dependent protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YEATS4 |
Protein name | YEATS domain containing 4 YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1) |
Synonyms | GAS41 |
Description | FUNCTION: Chromatin reader component of the NuA4 histone acetyltransferase (HAT) complex, a complex involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A . Specifically recognizes and binds acylated histone H3, with a preference for histone H3 diacetylated at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac) or histone H3 diacetylated at 'Lys-14' and 'Lys-27' (H3K14ac and H3K27ac) . Also able to recognize and bind crotonylated histone H3 . May also recognize and bind histone H3 succinylated at 'Lys-122' (H3K122succ); additional evidences are however required to confirm this result in vivo . Plays a key role in histone variant H2AZ1/H2A.Z deposition into specific chromatin regions: recognizes and binds H3K14ac and H3K27ac on the promoters of actively transcribed genes and recruits NuA4-related complex to deposit H2AZ1/H2A.Z . H2AZ1/H2A.Z deposition is required for maintenance of embryonic stem cell (By similarity). . |
Accessions | O95619 ENST00000552955.1 ENST00000549685.5 F8W0J4 F8W1B9 ENST00000548020.5 ENST00000247843.7 F8VTR4 |